All In MedTech

Device Trial Radar · NCT07748572

PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France

CEFloW (Clinical Experience With Flow Diverter With and Without Movable Wire)

Last checked: Nov 20, 2026Latest source record: Aug 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Mar 7, 2025

Primary completion

Oct 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Phenox GmbHNot on our public-company list
Sponsor type
Industry
First posted
Aug 5, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.

Conditions

  • Intracranial Aneurysms

Interventions

  • Aneurysm treatment with a Flow Modulation DeviceDevice

    Treatment of an intracranial aneurysm (anterior and posterior circulation) with a p64, p48 MW, or p64 MW Flow Modulation Device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Morbi-Mortality RateTime frame: 12 Months

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • CHU Amiens-Picardie

    Amiens, France · Recruiting

  • CHU Bordeaux

    Bordeaux, France · Recruiting

  • CHU Pierre Wertheimer

    Bron, France · Recruiting

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.